105 related articles for article (PubMed ID: 21270619)
1. Phase II trial of capecitabine and cisplatin in advanced, persistent, or recurrent carcinoma of the cervix.
Errihani H; M'rabti H; Ismaili N; Inrhaoun H; Elghissassi I
Int J Gynecol Cancer; 2011 Feb; 21(2):373-7. PubMed ID: 21270619
[TBL] [Abstract][Full Text] [Related]
2. Phase II evaluation of capecitabine in refractory nonsquamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Blessing JA; Michener CM; Rubin S; Ramirez PT;
Int J Gynecol Cancer; 2008; 18(4):773-8. PubMed ID: 17892452
[TBL] [Abstract][Full Text] [Related]
3. A pilot phase II study of capecitabine plus cisplatin in the treatment of recurrent carcinoma of the uterine cervix.
Benjapibal M; Thirapakawong C; Leelaphatanadit C; Therasakvichya S; Inthasorn P
Oncology; 2007; 72(1-2):33-8. PubMed ID: 17998788
[TBL] [Abstract][Full Text] [Related]
4. Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gynecologic oncology group study.
Garcia AA; Blessing JA; Darcy KM; Lenz HJ; Zhang W; Hannigan E; Moore DH
Gynecol Oncol; 2007 Mar; 104(3):572-9. PubMed ID: 17049588
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy.
Chua DT; Sham JS; Au GK
Oral Oncol; 2003 Jun; 39(4):361-6. PubMed ID: 12676255
[TBL] [Abstract][Full Text] [Related]
6. Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Peng PJ; Ou XQ; Chen ZB; Liao H; Peng YL; Wang SY; Zhang HY; Lin Z
Cancer Chemother Pharmacol; 2013 Aug; 72(2):323-8. PubMed ID: 23728706
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
[TBL] [Abstract][Full Text] [Related]
8. Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Domingo E; Lorvidhaya V; de Los Reyes R; Syortin T; Kamnerdsupaphon P; Lertbutsayanukul C; Vito-Cruz E; Tharavichitkul E; Jin K; Yoshihara M; Cupino N; Lertsanguansinchai P
Oncologist; 2009 Aug; 14(8):828-34. PubMed ID: 19661184
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
Burnett AF; Roman LD; Garcia AA; Muderspach LI; Brader KR; Morrow CP
Gynecol Oncol; 2000 Jan; 76(1):63-6. PubMed ID: 10620443
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer.
Hong YS; Lee J; Lee SC; Hwang IG; Choi SH; Heo JS; Park JO; Park YS; Lim HY; Kang WK
Cancer Chemother Pharmacol; 2007 Aug; 60(3):321-8. PubMed ID: 17143602
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin plus capecitabine as first-line chemotherapy for recurrent or metastatic head and neck squamous cell cancer: experience outside of a trial setting.
McPartlin AJ; Mais K; Barker C; Swindell R; Mitchell K; Sykes A; Lee L; Yap B; Slevin NJ
Chemotherapy; 2013; 59(1):1-7. PubMed ID: 23635527
[TBL] [Abstract][Full Text] [Related]
12. Phase I and pharmacokinetic study of the association of capecitabine-cisplatin in head and neck cancer patients.
Pivot X; Chamorey E; Guardiola E; Magné N; Thyss A; Otto J; Giroux B; Mouri Z; Schneider M; Milano G
Ann Oncol; 2003 Oct; 14(10):1578-86. PubMed ID: 14504061
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of cisplatin and capecitabine in patients with squamous cell carcinoma of the head and neck, and correlative study of angiogenic factors.
Hitt R; Jimeno A; Rodríguez-Pinilla M; Rodríguez-Peralto JL; Millán JM; López-Martín A; Brandariz A; Peña C; Cortés-Funes H
Br J Cancer; 2004 Dec; 91(12):2005-11. PubMed ID: 15597103
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of capecitabine and cisplatin combination as first-line chemotherapy in Chinese patients with metastatic nasopharyngeal carcinoma.
Li YH; Wang FH; Jiang WQ; Xiang XJ; Deng YM; Hu GQ; Xu DM; Chen Y; Lin Q; He YJ
Cancer Chemother Pharmacol; 2008 Aug; 62(3):539-44. PubMed ID: 18172651
[TBL] [Abstract][Full Text] [Related]
15. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
16. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
[TBL] [Abstract][Full Text] [Related]
17. An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors.
Oechsle K; Honecker F; Kollmannsberger C; Rick O; Grünwald V; Mayer F; Hartmann JT; Bokemeyer C
Anticancer Drugs; 2007 Mar; 18(3):273-6. PubMed ID: 17264758
[TBL] [Abstract][Full Text] [Related]
18. [Capecitabine combined with cisplatin as first-line therapy in Chinese patients with advanced gastric carcinoma-a phase II clinical study].
Hu B; Yu JR; Wen ZZ; Shu YQ; Wang BC; Yin HR; Chen L; Bai YX; Liang J; Chen L; Cheng Y; Shen L; Zhou Y; Zhang HG; Li J; Wan DS; Chen S; Jia TZ; Jin ML
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):940-3. PubMed ID: 19173999
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of capecitabine and cisplatin as first-line combination therapy in patients with gastric cancer recurrent after fluoropyrimidine-based adjuvant chemotherapy.
Kang HJ; Chang HM; Kim TW; Ryu MH; Sohn HJ; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
Br J Cancer; 2005 Jan; 92(2):246-51. PubMed ID: 15655540
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Lee J; Im YH; Cho EY; Hong YS; Lee HR; Kim HS; Kim MJ; Kim K; Kang WK; Park K; Shim YM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):77-84. PubMed ID: 17762932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
